Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

OXYCODONE HYDROCHLORIDE TABLETS

Awarded
SPE2DP26F8660Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded contract SPE2DP26F8660 to DMS Pharmaceutical Group Inc on August 26, 2026, for the procurement of Oxycodone Hydrochloride Tablets. This award is a delivery order issued under the broader commercial items base administrative contract SPE2DX25D9900, which was originally established on April 2, 2025, with a total award value of 19,999,999.00 dollars. The specific order falls under NAICS code 424210 and is managed by the DLA Troop Support Medical Supply Chain FSB. Under this specific delivery order, the contractor is tasked with providing 1,000 bottles of Oxycodone Hydrochloride Tablets, identified by NSN 6505013053145. The total value for this line item is 12,120.00 dollars. The agreement includes established terms for destination delivery, inspection, and acceptance, as well as specific payment and FOB details as outlined in the order for supplies or services.

General Info

DLA awarded DMS Pharmaceutical Group $12,120 for 1,000 bottles of Oxycodone Hydrochloride Tablets.

Contract Value

$12.12

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2DP-26-F-8660 Order for Supplies or Services

PDF, Low priorityaward
Low

SPE2DX-25-D-9900 Commercial Items Contract / Award

PDF, Low priorityaward
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F8660 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $12.12 Award Date: 08-26-2026 Delivery order under: SPE2DX25D9900 Line items: - OXYCODONE HYDROCHLORIDE TABLETS (NSN/Part 6505013053145, PR 7017450476)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
International
Pralidoxime
Solicitation # W6369-26-A033/B
The Department of National Defence, through the Strategic Medical Countermeasures Program, is soliciting offers for the procurement of Pralidoxime Chloride or Pralidoxime Methyl Sulfate to treat Canadian Armed Forces members exposed to chemical warfare agents. The contract includes an initial requirement for 450 treatment courses to be delivered by March 31, 2027, with optional requirements for an additional 600 doses to be delivered between April 1, 2027, and March 31, 2031. A treatment course is defined as 1 gram per day for seven days. The award will be granted to the compliant offer with the lowest evaluated price, based on Delivered at Place terms for the Central Medical Equipment Depot in Petawawa, Ontario. Technical requirements mandate that the product be manufactured according to current Good Manufacturing Practices and hold a Health Canada issued Notice of Compliance or appropriate authorization. The medication must have a minimum shelf-life of 36 months from the date of manufacture and be delivered in a temperature-controlled environment, specifically maintained between 2 to 8 degrees Celsius, with continuous electronic monitoring and a Certificate of Conformity provided upon delivery. All packaging and drug inserts must be available in English or French. There are no security requirements associated with this procurement, and the solicitation is open to Canadian suppliers and those of applicable trading partners.
Department of National Defence

POSTED

2 days ago

DEADLINE

in 19 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS